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Abstract
 
The fungus 
 
Candida albicans
 
 behaves as a commensal as well as a true pathogen of areas highly
enriched in dendritic cells, such as skin and mucosal surfaces. The ability of the fungus to re-
versibly switch between unicellular yeast to filamentous forms is thought to be important for
virulence. However, whether it is the yeast or the hyphal form that is responsible for pathoge-
nicity is still a matter of debate. Here we show the interaction, and consequences, of different
forms of 
 
C
 
.
 
 albicans
 
 with dendritic cells. Immature myeloid dendritic cells rapidly and efficiently
phagocytosed both yeasts and hyphae of the fungus. Phagocytosis occurred through different
phagocytic morphologies and receptors, resulting in phagosome formation. However, hyphae
escaped the phagosome and were found lying free in the cytoplasm of the cells. In vitro, inges-
tion of yeasts activated dendritic cells for interleukin (IL)-12 production and priming of T
helper type 1 (Th1) cells, whereas ingestion of hyphae inhibited IL-12 and Th1 priming, and
induced IL-4 production. In vivo, generation of antifungal protective immunity was induced
upon injection of dendritic cells ex vivo pulsed with 
 
Candida 
 
yeasts but not
 
 
 
hyphae. The immu-
nization capacity of yeast-pulsed dendritic cells was lost in the absence of IL-12, whereas that of
hypha-pulsed dendritic cells was gained in the absence of IL-4. These results indicate that den-
dritic cells fulfill the requirement of a cell uniquely capable of sensing the two forms of 
 
C
 
.
 
 albi-
cans
 
 in terms of type of immune responses elicited. By the discriminative production of IL-12
and IL-4 in response to the nonvirulent and virulent forms of the fungus, dendritic cells appear
to meet the challenge of Th priming and education in 
 
C
 
.
 
 albicans
 
 saprophytism and infections.
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Introduction
 
Candida albicans
 
 is the most frequently isolated fungal
pathogen in humans (1). In mucosal colonization and sys-
temic infection of mice with the fungus, Th1 cells mediate
phagocyte-dependent protection and are the principal me-
diators of acquired protective immunity. In contrast, pro-
duction of inhibitory cytokines such as IL-4 and IL-10 by
Th2 cells and high levels of IgE are associated with disease
progression (2–4). Th2-like reactivity is frequently ob-
served in patients with 
 
Candida
 
-related pathology, such as
in symptomatic infections (5) and allergy (6). Th1-type re-
sponses may thus characterize the carriage of saprophytic
yeast and the resistance to disease seen in healthy humans,
whereas Th2 responses associate predominantly with pa-
thology (7, 8).
In murine candidiasis, Th1 differentiation requires the
combined effects of different cytokines, including IL-12, in
the relative absence of counterregulatory cytokines, such as
IL-4 and IL-10, which are, by themselves, necessary and
sufficient to drive Th2 polarization (9). Although deficient
IFN-
 
g
 
, TGF-
 
b
 
, IL-6, and TNF-
 
a
 
 responses may each
block the induction of protective immunity, none of these
cytokines is as correlative of Th1 development as IL-12 (9).
This cytokine was both required and prognostic for the de-
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velopment of protective Th1 responses to 
 
Candida 
 
(10, 11),
and acted as an adjuvant in response to a 
 
Candida
 
 vaccine
(12). The availability of IL-12 at the level of the antigen
recognition triad (APC, antigen, CD4
 
1
 
 cells) allows the
latter cells to differentiate into Th1 cells and to initiate cell-
mediated immunity to the fungus. Therefore, understand-
ing cell sources and fungal antigen(s) for IL-12 release has
fundamental implications for immunity, vaccine, and ther-
apy of 
 
C
 
.
 
 albicans
 
 infections and pathology.
 
C
 
.
 
 albicans
 
 can switch from a unicellular yeast form into
various filamentous forms, all of which can be found in in-
fected tissues (13). The ability to reversibly switch between
these forms is thought to be important for 
 
Candida
 
’s viru-
lence (14).
 
 
 
Although recent studies have clearly shown that
the ability to switch from yeast to filamentous form is re-
quired for virulence (15, 16), whether it is the yeast or the
hyphal form that is responsible for pathogenicity is still an
open question. Other pathogenic fungi appear to prolifer-
ate in the host exclusively as yeast form cells (17–19). One
possibility is that the filamentous growth form is required
to evade the cells of the immune system, whereas the yeast
form may be the mode of proliferation in infected tissues.
For this to be possible, a cell must exist that finely discrimi-
nates between the two forms of the fungus in terms of class
of immune response elicited. Recent evidence in mice in-
dicates that neutrophils discriminate between the two
forms of the fungus, being able to produce IL-12 in re-
sponse to 
 
C
 
.
 
 albicans
 
 yeasts and IL-10 in response to 
 
C
 
.
 
 albi-
cans
 
 hyphae (20, 21).
With the recognition that dendritic cells (DCs)
 
1
 
 are
uniquely able to initiate responses in naive T cells and that
DCs also participate in Th cell education (22, 23), the
present study was undertaken to understand whether DCs
interact with 
 
C
 
.
 
 albicans 
 
in its different forms, and to eluci-
date possible mechanisms and consequences of this in-
teraction. This issue appears to be particularly relevant in
candidiasis, considering that the fungus behaves as a com-
mensal as well as a true pathogen of skin and mucosal sur-
faces (13), known to be highly enriched in DCs. For adap-
tive immune responses to be mounted against fungi, it
would seem necessary that DCs should be phagocytic at
some stage in their life cycle. Therefore, we have taken ad-
vantage of an immature myeloid DC line established from
fetal mouse skin (FSDC [24]), capable of efficiently stimu-
lating T cells in vitro and in vivo, upon cytokine treatment
(25). In a system devoid of contaminating cells, we found
that FSDCs ingested both yeasts and hyphae of the fungus,
apparently through different phagocytic mechanisms. Both
forms of the fungus were found inside phagosomes. How-
ever, hyphae escaped the phagosome and were lying free in
the cytoplasm of the cells. In vitro, ingestion of yeasts acti-
vated FSDCs and purified splenic DCs for IL-12 produc-
tion and priming of Th1 cells, whereas ingestion of hyphae
 
inhibited IL-12 and Th1 priming and induced IL-4 pro-
duction. In vivo, generation of antifungal protective im-
munity was observed upon injection of DCs ex vivo pulsed
with 
 
C
 
.
 
 albicans 
 
yeasts but not hyphae. However, the im-
munization capacity of yeast-pulsed DCs was lost in the ab-
sence of IL-12 and that of hypha-pulsed DCs was gained in
the absence of IL-4. Therefore, DCs, by discriminating be-
tween the virulent and nonvirulent forms of the fungus, are
responsible for Th priming and education in 
 
C
 
.
 
 albicans
 
saprophytism and infection.
 
Materials and Methods
 
Mice.
 
BALB/c (
 
H-2
 
d
 
), and (C57BL/6 
 
3
 
 DBA/2)F1
(B6D2F1), 
 
H-2
 
b
 
/
 
H-2
 
d
 
 
 
mice, 8–10 wk old of both sexes, were
purchased from Charles River. IL-4–deficient and
 
 
 
IL-12 p40–
deficient (knockout [KO]) mice on BALB/c background (provided
by Dr. Manfred Kopf, Basel Institute for Immunology, Basel,
Switzerland; and Dr. Luciano Adorini, Roche Milan, Milan, It-
aly, respectively [26]) and wild-type (WT) mice were bred under
specific pathogen-free conditions in the Animal Facility of Peru-
gia University. Procedures involving animals and their care were
conducted in conformity with national and international laws and
policies.
 
C. albicans Strains and Culture Conditions.
 
The origin and
characteristics of the 
 
C
 
.
 
 albicans
 
 highly virulent CA-6 strain and
the live vaccine strain, PCA-2, used in this study have already
been described in detail (10, 11). Because the CA-6 strain is capa-
ble of undergoing yeast to hyphal transition in vitro (27), whereas
the PCA-2 strain is not, the CA-6 and PCA-2 strains were used
as sources of hyphae and yeasts, respectively. For phagocytosis of
hyphae, the CA-6 cells were allowed to germinate by culture at
37
 
8
 
C, 5% CO
 
2
 
, for 2 h in RPMI 1640 medium with 10% heat-
inactivated FCS (by that time, 
 
.
 
98% of cells had germinated)
(27). The hyphae were then harvested, counted, and resuspended
in IMDM (GIBCO BRL) containing 5% filtered heat-inactivated
FCS and 50 
 
m
 
g/ml gentamicin (GIBCO BRL). For phagocytosis
of yeasts, the PCA-2 cells were harvested at the end of the expo-
nential phase of growth, centrifuged, and resuspended in the
above medium. For yeast opsonization, the PCA-2 yeasts were
exposed to RPMI 1640 medium with 10% heat-inactivated FCS
for 2 h at 37
 
8
 
C, 5% CO
 
2
 
. Systemic infection of BALB/c and
B6D2F1 mice with CA-6 resulted in a progressive, Th2-associ-
ated disease, whereas infection with PCA-2 resulted in a Th1-
mediated, self-limiting infection (28).
 
Propagation of FSDCs.
 
Immature FSDCs were generated by
retroviral immortalization as described previously (24, 25). Cells
were cultured in IMDM containing 5% filtered FCS, 50 
 
m
 
M
2-ME, 2 mM 
 
l
 
-glutamine, and 50 
 
m
 
g/ml gentamicin (complete
medium). For routine passaging, the cells were detached from tis-
sue culture flasks (Falcon Labware) with 2 mM EDTA in PBS.
 
Phagocytic Assay.
 
FSDCs
 
 
 
(5 
 
3
 
 10
 
5 
 
cells/100 
 
m
 
l of complete
medium) were incubated at 37
 
8
 
C with 
 
C
 
.
 
 albicans
 
 yeasts or hy-
phae (2.5 
 
3
 
 10
 
5
 
 cells/100 
 
m
 
l of complete medium) in suspension
culture dishes (Falcon Labware) for 60 min. For mannan inhibi-
tion, cells were first incubated with different concentrations of
mannan from 
 
Saccharomyces cerevisiae
 
 (Sigma-Aldrich) for 3 min,
before addition of fungal cells, as described (25). Phagocytic cells
were separated from nonphagocytosed 
 
C
 
.
 
 albicans
 
 cells by centrif-
ugation on a fetal bovine serum gradient, and a 0.1-ml sample of
the harvested phagocytic cells was used for cytospin preparation.
After Diff-Quik staining, the fungal cell internalization was ex-
 
1
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linked immunospot assay; HPRT, hypoxanthine-guanine phosphoribo-
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pressed according to the following formula: percentage of inter-
nalization 
 
5 
 
number of cells containing one or more fungal cells/
100 cells counted.
 
Transmission Electron Microscopy.
 
For transmission electron
microscopy (TEM), FSDCs were incubated in suspension culture
dishes with 
 
C
 
.
 
 albicans 
 
yeasts or hyphae, as in the phagocytic assay,
for times varying between 15 min and 4 h. A total of 5 
 
3
 
 10
 
5
 
cells were pelleted at 1,200 rpm for 5 min, washed twice with
PBS, and fixed in cold 2.5% glutaraldehyde in 0.1 M sodium ca-
codylate/1% sucrose buffer for 2 h.
 
 
 
The cells were postfixed in
1% osmium tetroxide (50 min), encapsulated in 1% agar, stained
with uranyl acetate and phosphotungstic acid, and dehydrated in
a series of graded ethanolic solutions finishing with propylene ox-
ide before finally being embedded in Epon 812-Araldite mixture.
Ultrathin sections (50 nm) were cut on an ultramicrotome (LKB
Wallac) and placed under 200-mesh standard copper grids, con-
trasted with uranyl acetate and lead citrate, and examined with a
Philips TEM 400 transmission electron microscope.
 
Candidacidal Assay and Nitric Oxide Production.
 
For the candi-
dacidal assay, 5 
 
3
 
 10
 
5
 
 FSDCs (100 
 
m
 
l/well) were plated in 96-
well flat-bottomed microtiter plates (Costar) and incubated with
different numbers of 
 
C
 
.
 
 albicans 
 
yeasts or hyphae for 2 and 4 h, re-
spectively, as described (29). Triton X-100 was then added to the
wells, and serial dilutions from each well were made in distilled
water. Pour plates (four to six replicate samples) were made by
spreading each sample on Sabouraud glucose agar. The number
of CFU was determined after 18 h of incubation at 37
 
8
 
C, and the
percentage of CFU inhibition (mean 
 
6 
 
SE) was determined as
follows: percentage of colony-forming inhibition 
 
5 
 
100 
 
2
 
 (CFU
experimental group/CFU control cultures) 
 
3
 
 100. Control cul-
tures consisted of
 
 C
 
.
 
 albicans
 
 cells incubated without effector cells.
For nitrite determination, a measure of nitric oxide (NO) synthe-
sis, FSDCs were cultured as above or in the presence of IFN-
 
g
 
(400 U/ml) and LPS (40 ng/ml) for 18 h before assaying NO
production in the culture supernatants, by a standard Griess reac-
tion, as described previously (29).
 
Purification and Candida Pulsing of DCs.
 
DCs were purified
from spleens by magnetic cell sorting with MicroBeads conju-
gated to hamster anti–mouse CD11c mAbs (clone N418), ac-
cording to the manufacturer’s instructions (Miltenyi Biotec). In
brief, after overnight plastic adherence to remove macrophages,
10
 
8
 
 collagenase D (Sigma-Aldrich)–treated nonadherent spleen
cells were reacted with 100 
 
m
 
l of CD11c MicroBeads before
magnetic separation. Positively selected DCs (at 
 
z1% yield re-
covery) routinely contained .90% N418high cells. In accordance
with previous reports (30–32), CD111 purified DCs express high
levels of MHC class II antigen and comprise both CD8a and
DEC-205, high and low populations, on FACS® analysis. FSDCs
or purified DCs were pulsed with live yeasts or hyphae, as de-
tailed in the phagocytic assay, for 2 h before addition of 2.5 mg/
ml of Amphotericin B (Sigma-Aldrich) to prevent Candida over-
growth. Cells and supernatants, to be assessed for cytokine gene
expression and cytokine content, were harvested either immedi-
ately (2 h exposure) or at 6, 24, and 48 h of culture. Control ex-
periments indicated that Amphotericin B alone did not modify
patterns of cytokine gene expression and production by DCs.
In Vitro Activation of CD41 T Cells by Candida-pulsed DCs.
Purified (.90% pure on FACS® analysis) CD41 T splenocytes
were obtained by positive selection as described (10, 11). Irradi-
ated (2,000 rads), 18 h–pulsed FSDCs or purified DCs were cul-
tured (5 3 105/ml) with 5 3 106/ml CD41 T cells, in 24-well
tissue culture plates (Falcon Labware) for 5 d in complete me-
dium. In cocultures of hypha-pulsed FSDCs or DCs, 50 U/ml of
human IL-2 (Hoffmann-La Roche) were added. Subsequently,
cells were washed and restimulated (5 3 106/ml) with heat-inac-
tivated Candida cells (5 3 105/ml) in the presence of irradiated,
T-depleted splenocytes (APCs; 5 3 106/ml) and IL-2 for 72 h
before cytokine determination in culture supernatants. This pro-
cedure allowed for successful priming of IL-4–producing CD41
T cells in vitro (33). For lymphoproliferation, 5 3 106 primed
CD41 T cells were cultured in 200 ml complete medium, in flat-
bottomed 96-well microtiter plates (Falcon Labware) in the pres-
ence of APCs, heat-inactivated Candida cells, and IL-2 for 4 d at
378C under 5% CO2. 8 h before harvesting, cells were pulsed
with 0.5 mCi of [3H]thymidine per well. Incorporation into cel-
lular DNA was measured by liquid scintillation counting. The re-
sults are expressed as mean cpm of stimulated cells, after subtrac-
tion of cpm of unstimulated cells.
Adoptive Immunization, Fungal Challenge, and Assessment of Pro-
tection. According to preliminary experiments performed to
evaluate route, dose, and schedule of DC administration, splenic
DCs, either unpulsed or after 18 h pulsing with yeasts or hyphae,
were subcutaneously injected, a week apart, at a concentration of
5 3 105 cells/mouse, in 20 ml of PBS. 7 d after the last immuni-
zation, the priming of Th cells in vivo was assessed by evaluating
the intracellular content of IFN-g and IL-4 in CD41 T spleno-
cytes (see below). For infection, mice were intravenously in-
fected with the virulent CA-6 C. albicans strain, 3 3 105 cells/0.5
ml of PBS. Protection was assessed by quantifying the number of
CFU (mean 6 SE) recovered from kidneys, and by parameters of
adaptive Th immunity such as the pattern of antigen-specific cy-
tokine production and proliferation. For patterns of cytokine
production, 106 splenocytes were stimulated with 105 heat-inacti-
vated C. albicans cells for 48 h. Lymphoproliferation of purified
CD41 T cells from spleens was done as above.
Cytokine Assays. The levels of IFN-g, IL-4, and IL-10 in
culture supernatants were determined by means of cytokine-spe-
cific ELISA using pairs of anticytokine mAbs, as described (10,
11). The antibody pairs used were as follows, listed by capture/
biotinylated detection: IFN-g, R4-6A2/XMG1.2; IL-4, BVD4-
1D11/BVD6-24G2.3; IL-10, JES5-2A5/SXC-1 (BD PharMin-
gen). IL-12 p70 was determined by the DuoSet ELISA (R&D
Systems). Cytokine titers were calculated by reference to standard
curves constructed with known amounts of recombinant cyto-
kines (from BD PharMingen, or Genetics Institute [for IL-12]).
Intracellular Cytokine Determination. CD41 T cells were puri-
fied from spleens of mice injected with unpulsed or Candida-
pulsed DCs, as described above. Cells (5 3 106/ml) were cul-
tured in vitro with heat-inactivated Candida (5 3 105/ml) cells,
APCs (5 3 106/ml), and 50 U/ ml IL-2 in 24-well tissue culture
plates. After 72 h of culture, living cells separated on Ficoll gradi-
ent were restimulated with PMA (1 mg/ml; Sigma-Aldrich) and
ionomycin (50 ng/ml; Sigma-Aldrich) for 4 h at 378C, with 10
mg/ml brefeldin A added for the last 2 h to promote intracellular
accumulation of secreted proteins. Cells were stained for intracel-
lular IFN-g and IL-4 by using the Cytofix/Cytoperm kits (BD
PharMingen), as per the manufacturer’s instructions. Analysis was
performed with a FACScan™ flow cytometer (Becton Dickin-
son) equipped with CELLQuest™ software, and was based on
2 3 105 events live-gated according to forward and side scatter
characteristics.
Enzyme-linked Immunospot Assay. IL-4–producing FSDCs
were enumerated by enzyme-linked immunospot (ELISPOT) as-
say, as described (21). In brief, FSDCs were exposed to C. albicans
yeasts or hyphae for 2 h, before addition of amphotericin B to
prevent fungal overgrowth. Subsequently, cells were extensively1664 Dendritic Cells in Candidiasis
washed and cultured (102–104 cells/well) in complete medium for
18 h in 96-well plates previously coated with BVD4-1D11 mAb.
Biotinylated BVD6-24G2 mAb was used as the detecting re-
agent, the enzyme was avidin-alkaline phosphatase conjugate
(Vector Laboratories), and the substrate was 5-bromo-4-chloro-
3-indolyl phosphate-p-toluidine salt (Life Technologies). Results
were expressed as the mean number of IL-4–producing cells (6
SE) per 104 cells, calculated using replicates of serial twofold dilu-
tions of FSDCs.
Reverse Transcriptase PCR. RNA extraction and amplifica-
tion of synthesized cDNA from FSDCs were done as described
(10, 11). For hypoxanthine-guanine phosphoribosyltransferase
(HPRT) and cytokines, the primers, positive controls, cycles, and
temperature were as described elsewhere (10, 11). The HPRT
primers were used as a control for both reverse transcription and
the PCR reaction itself, and also for comparing the amount of
products from samples obtained with the same primer. The PCR
fragments were analyzed by 1.5% agarose gel electrophoresis and
visualized by ethidium bromide staining. PCR-assisted mRNA
amplification was repeated at least twice for at least two separately
prepared cDNA samples for each experiment.
Statistical Analysis. Student’s t test was used to determine sig-
nificance of values among experimental groups (significance was
defined as P , 0.05). In vivo groups consisted of six to eight ani-
mals. The data reported were pooled from three to five experi-
ments.
Results
FSDCs Internalize Both Yeasts and Hyphae of C. albicans.
Neutrophils and macrophages are recognized as the pro-
totypical phagocytic cells of C. albicans (34, 35). To de-
termine whether DCs also phagocytose C. albicans, FSDCs
were exposed to either yeasts or hyphae of the fungus, and
internalization of fungal cells was evaluated at different
times after exposure, by light microscopy and TEM. Light
microscopic observations suggested that FSDCs ingest both
yeasts and hyphae of C. albicans in a time-dependent man-
ner, with optimum phagocytosis between 20 and 30 min.
Opsonization of the yeasts in serum did not enhance phago-
Figure 1. TEM of phagocytosis of C. al-
bicans by DCs. FSDCs were incubated with
C. albicans yeasts (A, C, and D) or hyphae
(B, E, F, and G) at an FSDC/C. albicans ra-
tio of 2:1, for 15 min (A and B), 1 h (E–G),
2 h (C), and 4 h (D) before processing for
TEM. (A) Yeast engulfment through coil-
ing phagocytosis and (B) hypha uptake
through zipper-type phagocytosis, at 15 min
after infection. (C) Fungal elements inside
phagolysosomes at 2 h after exposure (ar-
rows), and (D) in partially degraded forms at
4 h after exposure (arrow). (E) Hyphae es-
caping the phagosome at 2 h, and (F and G)
lying free in the cytoplasm. Original magni-
fications: (A) 317,000; (B) 312,000; (C)
37,000; (D) 322,000; (E) 312,000; (F)
312,000; and (G) 370,000. Bar, (A–C, E,
F) 1 mm; (D) 0.5 mm; and (G) 0.1 mm.1665 Fè d’Ostiani et al.
cytosis. Apparently, FSDCs phagocytosed more yeasts
than did neutrophils (data not shown). TEM revealed that
just 15 min after infection, yeasts (Fig. 1 A) and hyphae
(Fig. 1 B) had already been engulfed by FSDCs. Interest-
ingly, the uptake of fungal cells occurred through different
forms of phagocytosis. Internalization of yeasts occurred
predominantly by coiling phagocytosis (Fig. 1 A), charac-
terized by the presence of overlapping bilateral pseudopods,
that led to a pseudopodal stack before transforming into a
phagosome wall. In contrast, entry of hyphae occurred by a
more conventional, zipper-type phagocytosis, characterized
by the presence of symmetrical pseudopods, which strictly
followed the contour of the hyphae before fusion (Fig. 1
B). 2 h later, numerous yeast cells were found inside phago-
somes (Fig. 1 C), and were partially degraded at 4 h (Fig.
1 D). Interestingly, as early as 1 h after infection, hyphae
appeared to escape the phagosome (Fig. 1 E) and were ly-
ing free in the cytoplasm of the cells (Fig. 1 F), as clearly
magnified in Fig. 1 G. These results show that DCs are en-
dowed with the ability to phagocytose both forms of the
fungus, and, importantly, each fungal form appears to be
internalized by different phagocytic mechanisms and to re-
side in different cell compartments.
As uptake of macromolecules, including zymosan, by
immature DCs and FSDCs could be blocked by mannan
(25, 36, 37), and mannose receptors were sufficient to me-
diate macrophage phagocytosis of C. albicans (35, 38), we
performed uptake experiments in the presence of mannan.
At concentrations of mannan known to inhibit the man-
nose receptor uptake by immature DCs (37), we observed
.80% inhibition of phagocytosis of yeast cells, and ,50%
inhibition of that of hyphae (Fig. 2).
FSDCs Behave as Antifungal Effector Cells. To assess
whether phagocytosis of C. albicans results in the activation
of the antifungal effector machinery in DCs, FSDCs were
assessed for the ability to inhibit the fungal growth and to
release NO upon exposure to Candida yeasts and hyphae.
The results (Fig. 3 A) showed that, as early as 2 h after ex-
posure, FSDCs inhibited the growth of yeasts and hyphae.
Both activities were higher against yeasts than hyphae, and
this correlated with the higher production of NO (Fig. 3
B) and expression of the inducible NO synthase (iNOS)
gene upon yeast exposure (not shown). Therefore, DCs
exhibit antifungal effector activities upon phagocytosis of
fungal cells.
Production of IL-12 and IL-4 by FSDCs and Purified DCs
Exposed to C. albicans Yeasts or Hyphae. The outcome of
encounters between antigen-bearing APCs and naive T
cells depends, in part, on the nature of the cytokines re-
leased locally by APCs. This is particularly relevant in can-
Figure 2. Effect of mannan on internalization of C. albicans by DCs. FS-
DCs were incubated with mannan at different concentrations for 10 min
before the addition of C. albicans yeasts (white bars) or hyphae (black bars)
at a ratio of 2:1 (FSDC/Candida). Internalized fungal cells were visualized
by light microscopy after 30 min of incubation, as described in Materials
and Methods. *P , 0.05, yeast or hypha internalization in the presence of
mannan vs. yeast or hypha internalization in the absence of mannan.
Figure 3. Antifungal activities of DCs. (A) FSDCs were exposed to C.
albicans yeasts or hyphae (FSDC/Candida ratios of 10:1, white bars; 5:1,
hatched bars; and 2.5:1, black bars) for 2 h before determination of CFU
inhibition, as described in Materials and Methods. (B) NO production by
DCs unexposed (None), or upon exposure to IFN-g (400 U/ml) and
LPS (40 ng/ml) or Candida yeasts or hyphae. *P , 0.05, hypha-pulsed vs.
yeast-pulsed DCs.
Figure 4. Cytokine gene expression by DCs after exposure of C. albi-
cans yeasts or hyphae. FSDCs were either unexposed (none) or exposed to
fungal cells at a ratio of 2:1 for different time periods before analysis by
RT-PCR. C, HPRT- or cytokine-specific control; N, no DNA added
to the amplification mix during PCR.1666 Dendritic Cells in Candidiasis
didiasis because development of Th1-predominant protec-
tive immunity is clearly dependent on production of IL-12,
in the relative absence of IL-4 (39). Therefore, we deter-
mined the pattern of cytokine production in FSDCs and
purified DCs exposed to C. albicans yeasts or hyphae, by
evaluating cytokine gene expression and production by re-
verse transcriptase (RT)-PCR, cytokine-specific ELISA,
and ELISPOT assay. Cells and supernatants were harvested
at 2, 6, 24, and 48 h of culture. Results of RT-PCR re-
vealed that the IL-12 p40 mRNA was continuously de-
tected upon incubation of FSDCs with yeasts, as opposed
to the IL-4 and IL-10 mRNA that were not detected at
any time (Fig. 4). The TNF-a message was maximally evi-
dent at 48 h. In contrast, the IL-12 p40 message was pro-
gressively disappearing upon exposure to hyphae, being re-
duced at 6 h after exposure and completely undetectable at
48 h. Instead, the IL-4 message was detected in hypha-
exposed FSDCs, being evident at 2 h after exposure. Similar
to yeast exposure, the IL-10 message was never detected.
The TNF-a message was continuously present. In terms of
protein production, IL-12 p70 was produced upon expo-
sure to yeasts, but not upon exposure to hyphae. In con-
trast, IL-4 was promptly detected upon phagocytosis of hy-
phae but not yeasts (Table I), and this correlated with an
elevated frequency of IL-4–producing FSDCs upon expo-
sure to hyphae (Fig. 5). According to cytokine gene ex-
pression, IL-10 was never detected (Table I), whereas com-
parable levels of TNF-a (523 vs. 476 pg/ml) were
measured at 48 h exposure to yeasts or hyphae. Levels of
TGF-b were never detectable in either type of culture
(data not shown). Similar to what was observed in the phago-
cytic assay, serum opsonization of the yeasts did not
change the pattern of cytokine production, as similar levels
of IL-12 p70 and no IL-4 or IL-10 were observed upon
exposure to opsonized yeasts (Table I). On measuring lev-
els of cytokine production by purified splenic DCs upon
exposure to yeasts or hyphae, a pattern similar to that ob-
served with FSDCs was found, in that production of IL-12
p70 occurred in response to yeasts and production of IL-4
in response to hyphae, and no IL-10 was detected (Table
I). These results indicate that, upon exposure to C. albicans
yeasts or hyphae, FSDCs and, importantly, purified splenic
DCs differentially produce IL-12 and IL-4.
Candida-exposed DCs Prime CD41 T Lymphocytes In Vitro.
To assess the ability of DCs exposed to C. albicans to ac-
tivate naive CD41 T cells in vitro, CD41 T splenocytes
from unprimed mice were cocultured with yeast- or hy-
pha-pulsed FSDCs or purified splenic DCs. After 5 d, the
primed cells were restimulated with APCs and Candida an-
tigens for an additional 72 h before measurement of cyto-
kines in secondary culture supernatants and for 96 h before
assessment of lymphoproliferation. The results (Fig. 6)
show that yeast-exposed FSDCs or yeast-exposed DCs in-
duced the production of IFN-g, but not IL-4 or IL-10. In
contrast, FSDCs or DCs exposed to hyphae induced low
Figure 5. Frequency of IL-4–producing cells in DCs exposed to C. al-
bicans. FSDCs were exposed to yeasts or hyphae, at a ratio of 2:1, for 18 h
before ELISPOT assay.
Table I. Production of IL-12 p70, IL-4, and IL-10 by FSDCs and Purified DCs upon Phagocytosis of C. albicans Yeasts or Hyphae
IL-12 p70* IL-4* IL-10*
Cells‡ Exposure to: 6 h 48 h 6 h 48 h 6 h 48 h
ng/ml ng/ml ng/ml
FSDCs None ,0.01 ,0.01 ,2 ,2 ,2 ,2
FSDCs Candida yeasts 2.4 6 0.7 3.1 6 0.7 ,2 ,2 ,2 ,2
FSDCs Candida yeasts§ 2.0 6 0.8 3.5 6 0.5 ,2 ,2 ,2 ,2
FSDCs Candida hyphae ,0.01 ,0.01 29 6 6 25 6 5 ,2 ,2
DCs None ,0.01 ,0.01 ,2 ,2 ,2 ,2
DCs Candida yeasts 2.1 6 0.8 2.7 6 0.3 ,2 ,2 ,2 ,2
DCs Candida hyphae ,0.01 ,0.01 16 6 3 23 6 4 ,2 ,2
Values indicated by “,” were below the limit of the assays, as per the manufacturer’s indications (see Materials and Methods).
*Cytokine levels (mean 6 SE) as determined by cytokine-specific ELISA.
‡FSDCs or purified splenic DCs were exposed to yeasts or hyphae at a cell to fungi ratio of 2:1 for 6 and 48 h before assessment of cytokine content
in culture supernatants.
§Candida yeasts were opsonized by exposure to RPMI 1640 with 10% heat-inactivated FCS for 2 h at 378C, 5% CO2.1667 Fè d’Ostiani et al.
levels of IFN-g, but high levels of IL-4 and IL-10. Priming
with Candida-pulsed FSDCs or DCs also induced CD41 T
cells to proliferate (Fig. 6). The proliferating activity of cells
primed by hypha-pulsed FSDCs or DCs was dependent on
IL-2, as no proliferation could be detected in the absence
of added IL-2. Instead, the high levels of IL-2 being pro-
duced in cultures of yeast-pulsed FSDCs or DCs (data not
shown) might have allowed the elevated proliferation ob-
served in these cultures (Fig. 6). Together, these results in-
dicate that, upon exposure to C. albicans yeasts or hyphae,
DCs acquire the ability to prime CD41 T cells for Th1 or
Th2 cytokine production in vitro.
Yeast-exposed DCs Prime CD41 Th1 Lymphocytes In Vivo
and Induce Protective Antifungal Immunity in Infected Mice.
To investigate whether Candida-pulsed DCs were capa-
ble of priming antigen-specific CD41 Th responses in vivo,
purified DCs, either unpulsed or pulsed with yeasts or hy-
phae, were adoptively transferred into mice by subcutane-
ous injection. 1 wk after the last injection, CD41 T cells
were purified from spleens, restimulated in vitro, and as-
sessed for cytokine production by intracellular staining.
Compared with control mice injected with unpulsed DCs,
the number of cells producing IFN-g was increased, and
the number of cells producing IL-4 decreased in mice
adoptively transferred with yeast-pulsed DCs as opposed to
what was observed in mice receiving hypha-pulsed DCs
(Fig. 7). To correlate this finding with the in vivo antifun-
gal resistance, mice received a sublethal dose of C. albicans
intravenously, 1 wk after the last DC injection. For com-
parison, a group of mice that was immunized by vaccina-
tion with the live PCA-2 vaccine strain was also included.
At 7 d after infection, mice were monitored for resistance
to infection and parameters of antigen-specific Th cell acti-
vation, such as lymphoproliferation and cytokine produc-
tion. The results (Fig. 8) show that resistance to infection
was greatly increased upon transfer of yeast-pulsed DCs, as
judged by the reduced number of CFU recovered from
kidneys, which was similar to that observed in vaccinated
mice. The number of CFU was not reduced upon transfer
of unpulsed or hypha-pulsed DCs, being actually increased
upon transfer of the latter. The analysis of antigen-specific
proliferation and cytokine production by CD41 T cells and
splenocytes revealed that resistance or susceptibility to in-
fection correlated with the activation of Th1 or Th2 cells,
respectively. Levels of IFN-g were higher, and those of IL-4
lower, in mice immunized with yeast-pulsed DCs or
PCA-2 compared with mice receiving unpulsed or hypha-
pulsed DCs. These results, together with those shown in
Fig. 7, indicate that adoptively transferred Candida-pulsed
DCs are able to prime specific antifungal Th responses in
vivo, the quality of which depends on forms of the fungus
and the nature of the cytokines. To directly address this is-
sue, purified splenic DCs from IL-12 KO mice were pulsed
with yeasts and those from IL-4 KO mice with hyphae,
Figure 6. In vitro activation of CD41 T cells by DCs upon exposure to
C. albicans. FSDCs (white bars) or purified splenic DCs (black bars), either
unexposed (none) or exposed to Candida yeasts or hyphae were cocultured
with responder CD41 T cells from naive B6D2F1 (for FSDCs) or BALB/c
(for purified splenic DCs) mice (see Materials and Methods for details).
After 5 d, cells were restimulated with fresh APCs (irradiated, T-depleted
splenocytes) and inactivated Candida cells for 72 h (for cytokine determi-
nation) or 96 h (for lymphoproliferation). Cytokines were determined by
specific ELISA (mean 6 SE, ng/ml). Lymphoproliferation was measured
by evaluating thymidine incorporation. The results are expressed as mean
cpm 6 SE of stimulated cells, after subtraction of cpm of unstimulated
cells. *P , 0.05, Candida-pulsed vs. unpulsed FSDCs or DCs.
Figure 7. Intracellular cytokine expres-
sion in CD41 T cells from BALB/c mice
upon adoptive transfer of Candida-pulsed
DCs. Splenic DCs, unpulsed (A) or ex vivo
pulsed with Candida yeasts (B) or hyphae
(C), were subcutaneously injected twice,
once a week, 7 d before collection of sple-
nocytes. For intracellular staining, purified
CD41 splenocytes were restimulated in
vitro with APCs and inactivated Candida
cells for 72 h. After washing, the cells were
further stimulated with PMA and ionomy-
cin in the presence of brefeldin A and then
stained for intracellular IFN-g and IL-4.
Percentages reflect cytokine-positive cells.1668 Dendritic Cells in Candidiasis
then assessed for their ability to prime CD41 T cells in
vitro and to elicit antifungal Th responses in vivo upon
transfer into WT mice. The results (Fig. 9) show that yeast-
pulsed DCs from IL-12 KO mice primed lymphocytes for
IL-4 production in vitro and were unable to confer resis-
tance to the infection, as opposed to similarly pulsed DCs
from WT mice. In contrast, hypha-pulsed DCs from IL-4
KO mice primed lymphocytes for IFN-g production and
were able to confer protection in vivo, as indicated by the
significant reduction of CFU in kidneys.
Discussion
The results of this study show that: (a) murine DCs in-
ternalize both yeasts and hyphae of C. albicans, through dis-
tinct phagocytic mechanisms; (b) both forms of the fungus
are found inside phagosomes, with signs of degradation,
but hyphae escape the phagosome and lie free in the cyto-
plasm; (c) phagocytosis of yeasts induces IL-12 production,
whereas that of hyphae inhibits IL-12 and induces IL-4
production; (c) yeast-pulsed DCs, as opposed to hypha-
pulsed DCs, activate Th1 lymphocytes in vitro and in vivo
and induce antifungal resistance upon adoptive transfer
into recipient mice. Thus, DCs fulfill the requirement of a
cell uniquely capable of discriminating between the two
forms of the fungus in terms of the type of immune re-
sponse elicited.
Unlike conventional phagocytic cells, such as neutro-
phils and macrophages that have had only the phagocytosis
of yeasts well documented (27, 34, 35), DCs easily phago-
cytosed both forms of the fungus, and, upon phagocytosis
of either form, produced sets of cytokines with opposing
activities in the developing immune response. Although
the coiling phagocytosis is now considered to reflect a dis-
turbance of the more conventional zipper-type phagocyto-
sis (40), DCs use both forms of phagocytosis to internalize
pathogens (41, 42). Here, we show that FSDCs engulfed
yeasts via coiling phagocytosis, as already observed during
uptake of yeasts or zymosan particles by phagocytic cells
(43). Once internalized, yeasts were detected in phagolyso-
somes, where different stages of progressive degradation
were seen. In contrast, internalization of hyphae appears to
occur through a more conventional zipper-type phagocy-
tosis. Once inside the cells, hyphae appeared to promote
rupture of the phagosomal membrane and escaped into the
cytoplasm. Thus, not only are yeasts and hyphae ingested
through different forms of phagocytosis, but, once inside
the cells, they reside in distinct cellular compartments. To
our knowledge, this is the first demonstration of (a) inter-
nalization of Candida hyphae through a phagocytic mecha-
nism, and (b) the ability of hyphae to escape and lie free in
the cytoplasm.
Yeasts and, to some extent, short filamentous forms of
C. albicans can be ingested by neutrophils (44, 45) and mac-
rophages (35, 46–48) through a variety of mechanisms and
opsonic requirements, ultimately affecting the antifungal
effector functions of the cells. Recently, an interesting ob-
servation was made on the fate of yeasts and filamentous
forms of C. albicans upon internalization in mouse mac-
rophages (48). Uptake of yeasts, but not of filamentous
forms, had the characteristics of phagocytosis, requiring in-
tact actin filaments and the activity of protein kinase C.
Once internalized, both forms of the fungus were found
inside phagosomes that rapidly fused with late endosomes
and lysosomes (48). Thus, the internalization and the intra-
cellular localization of the different forms of the fungus ap-
Figure 8. Effect of adoptively transferred DCs on C. albicans growth
and parameters of Th cell activation in mice with systemic candidiasis.
Splenic DCs, unpulsed (white bars) or ex vivo pulsed with Candida yeast
(black bars) or hyphae (hatched bars) were subcutaneously injected twice,
once a week, 7 d before intravenous infection with C. albicans virulent
strain. 7 d after infection, quantification of fungal growth was done in the
kidneys, cytokines were determined by specific ELISA in supernatants of
antigen-activated splenocytes, and lymphoproliferation of CD41 T cells
was assessed as in the legend to Fig. 6. Cross-hatched bars, mice vacci-
nated with the low-virulence C. albicans PCA-2, 2 wk before infection
with virulent C. albicans. *P , 0.05, Candida-pulsed DCs or vaccinated
mice vs. unpulsed DCs.
Figure 9. Effect of C. albicans–pulsed DCs from IL-12 KO or IL-4 KO
mice on Th cell priming in vitro and in vivo. Purified DCs from spleens
of mice with IL-12 p40 or IL-4 deficiency were ex vivo pulsed with Can-
dida yeasts or hyphae, respectively, and cocultured in vitro with purified
CD41 T splenocytes from WT mice or adoptively transferred into WT
recipients. Cocultures and cytokine determination were done as in the
legend to Fig. 6. Infection and quantification of fungal growth in vivo
were done as in the legend to Fig. 8. *P , 0.05, KO vs. WT mice.1669 Fè d’Ostiani et al.
pear to occur differently in macrophages and DCs. This
may reflect a distinction of labor between different phago-
cytic cells in the immune response to the fungus. Upon
contact with the fungus, effector macrophages and neutro-
phils rapidly activate oxidative and nonoxidative pathways
of killing through phagocytic and nonphagocytic mecha-
nisms (13). In contrast, the antifungal activity of DCs ap-
pears to be more tightly regulated, being expressed at
higher levels towards yeasts than hyphae. This may ulti-
mately have an impact on fungal antigen presentation by
DCs. Indeed, yeast degradation inside phagolysosomes
may result in an efficient release of fungal peptides for class
II–restricted antigen presentation, whereas hyphae surviv-
ing free in the cytosol may eventually intersect the class
I–restricted antigen presentation pathway. As both MHC
class II– and class I–restricted T cell responses have been
detected in mice with candidiasis (26, 49) and, interestingly
enough, the activation of CD81 T lymphocytes occurred
in response to the filamentous forms of the fungus (49), our
results suggest that DCs are uniquely qualified to serve as
APCs in antifungal host immune responses.
The reasons behind the different behavior of the two
forms of the fungus in different phagocytic cells are not
presently understood. Among other factors, C. albicans se-
cretes phospholipase C, a major virulent factor that in-
creases penetration of the fungus into host cell tissues (50).
It is interesting that phospholipase C contributes to the per-
foration of macrophage phagosomes by listeriolysin O (51).
It has been postulated that lysosomal fusion and acidifica-
tion of the vacuole might induce metabolic changes, in-
cluding enzyme secretion and activation, which may con-
tribute to pathogen infectivity (48). The existence of C.
albicans strains with deletion of the gene encoding the pre-
dominant phospholipase C (50) would allow us to directly
assess the role of this virulent factor in Candida trafficking
inside DCs.
The observation that internalization of yeasts, more than
hyphae, was sensitive to mannan inhibition not only sug-
gests that mannose receptors are involved in the entry of
Candida in FSDCs, but also indicates that additional recog-
nition molecules on DCs may participate in the phagocyto-
sis of hyphae. Receptors that have been identified on im-
mature DCs, including FSDCs (25), include lectins such as
the mannose receptor (52, 53) and DEC-205 (54), as well
as FceRI and FcgR (52, 55). Receptors for antigen capture
on dendritic and phagocytic cells vary in their ligand and
specificity and mode of delivery to antigen-processing
compartments (56–58). The mannose receptor–mediated
phagocytosis of nonopsonized C. albicans resulted in the
generation of proinflammatory cytokines (59), and the
mannose receptor–mediated phagocytosis of zymosan initi-
ated IL-12 production in phagocytes (60). In contrast, in-
teraction with receptors other than the mannose receptors,
including CR3 (61), led to suppression of the immune re-
sponse to C. albicans (46) and other fungi (62). Studies are
presently underway to understand whether DCs use differ-
ent receptors to phagocytose nonopsonized or opsonized
fungal elements. In this regard, it is worth mentioning that
in our experimental conditions, the exposure of yeasts to
serum in order to generate hyphae could have resulted in
opsonization of the latter, thus favoring the entry through
the FcgR. It has recently been reported that immune com-
plex internalization through the FcgR results in DC matu-
ration and MHC class I–restricted antigen presentation
(55). However, although it is an attractive hypothesis,
whether this also occurs with opsonized hyphae is not pres-
ently known. In the case of yeasts, serum opsonization did
not modify the extent of phagocytosis and cytokine pro-
duction by FSDCs, a finding in line with the observation
that the interaction of both opsonized and nonopsonized
fungal yeasts with macrophages (35) and neutrophils (45)
occurs predominantly through a mannose-specific mecha-
nism.
After phagocytosis of yeasts or hyphae, the downstream
cellular events were clearly different. Phagocytosis of yeasts
was a potent signal for sustained IL-12 production by both
FSDCs and purified DCs. A similar finding was obtained
upon exposure of FSDCs to Leishmania major amastigotes
(63). In contrast, phagocytosis of hyphae resulted in a pro-
gressive inhibition of IL-12 production. This inhibition
was not due to a generalized deactivation state, as TNF-a
production was not affected. Neither was it due to IL-10 or
TGF-b production, as neither cytokines were detected, a
finding in line with the observation that freshly isolated
DCs from spleens do not produce IL-10 (64). Surprisingly,
hypha-pulsed FSDCs and purified DCs produced IL-4, de-
tectable at message and protein levels, and in terms of fre-
quency of cytokine-producing cells. No IL-4 was observed
in unstimulated DCs, nor upon phagocytosis of yeasts. Pro-
duction of IL-4 was concomitant with inhibition of IL-12,
and although hypha-pulsed DCs from IL-4–deficient mice
produced IL-12, no data are presently available favoring the
hypothesis of a direct inhibitory effect of IL-4 on IL-12
gene transcription and protein production. Instead, one
likely possibility is an indirect effect of IL-4 through the in-
hibition of release of NO, known to induce IL-12 gene ex-
pression (65, 66). That IL-4 inhibits NO production in re-
sponse to C. albicans has already been reported (29). Here,
we found that production of NO by FSDCs was lower
upon hyphae compared with yeast internalization. Thus,
the impaired NO production not only correlates with the
decreased antifungal activity of cells toward hyphae, but
may also may represent a potent signal regulating IL-12
production in DCs.
One important consequence of phagocytosis of Candida
yeasts or hyphae by DCs is the ability of the cells to induce
different patterns of cytokine production by CD41 T
lymphocytes. Yeast-exposed DCs stimulated, and hypha-
exposed DCs inhibited, production of IFN-g and IL-2 by
unprimed CD41 T lymphocytes both in vitro and in vivo.
In contrast, IL-4 and IL-10 were observed in the presence
of hypha-exposed, but not yeast-exposed, DCs. Thus, mu-
rine DCs, upon phagocytosis of yeasts or hyphae of C. albi-
cans, acquire the capacity to induce the differentiation of
CD41 cells towards the Th1 or Th2 phenotype. This cor-
related in vivo with a different ability to control the infec-1670 Dendritic Cells in Candidiasis
tion in mice receiving yeast-pulsed DCs versus mice re-
ceiving hypha-pulsed DCs. The activation of antigen-
specific Th1 cells in the former nicely correlated with the
fungal burden, because the C. albicans growth was highly
restricted and similar to that observed in mice vaccinated
differently. The ability to induce anticandidal protective
Th1 immunity in vivo was impaired upon transfer of DCs
exposed to the yeasts in the absence of IL-12, and potenti-
ated upon transfer of DCs exposed to the hyphae in the
absence of IL-4. These results suggest that production of
IL-12 or IL-4 by DCs may crucially contribute to the in-
duction of protective and nonprotective immune responses
in C. albicans infection. These observations also ruled out
the possibility that the different capacity of yeast- or hypha-
pulsed DCs to activate antifungal immune responses is the
result of behaviors other than cytokine production, such as
homing and cell trafficking in vivo (67). All together, our
results would suggest that murine DCs, by producing sets
of opposing cytokines upon phagocytosis of yeasts or hy-
phae, may activate different anticandidal Th cells in vivo.
It is known that murine splenic DCs comprise two ma-
jor subpopulations of DCs, presumably belonging to dis-
tinct lineages, which differentially regulate the develop-
ment of Th cells in vivo (68–72). Although lymphoid
CD8a1 DCs, either directly (68, 71, 72) or indirectly (73),
were found to trigger the development of Th1 responses,
and myeloid CD8a2 DCs to induce Th2 responses, to
what extent, however, each subset contributes to the in-
duction or inhibition of T cell reactivity in vivo is still a
matter of debate (74, 75). In our experimental conditions,
the purified splenic population of DCs consisted of both
CD8a1 and CD8a2 cells. Whether these populations of
DCs would respond differently to the different forms of C.
albicans is an issue that we are presently addressing.
IL-4 has been the missing cytokine in the induction of
Th2 cell differentiation by DCs. The recent study by Ris-
soan et al. (71), in which two types of DCs were clearly
shown to be at work in Th1 and Th2 cell differentiation,
left open the question of the identity of the molecules re-
sponsible for Th2 cell induction by DCs, and factors in-
volved in the generation of functionally distinct types of
DCs. Our study, together with a recent paper (76) showing
production of IL-4 by DCs upon retroviral exposure, helps
clarify these issues by suggesting that exposure to patho-
gens, together with the ability to discriminate among them,
is an important determinant of DC and Th cell differentia-
tion. The capacity to produce IL-4 together with the pres-
ence of IL-4 on maturing DCs (77) indicates that autocrine
effects of this cytokine may indeed occur.
Accumulating evidence points to a unique role of DCs
in infections, as they are regarded as both sentinel for innate
recognition and initiator of Th cell differentiation and
functional commitment (78). Our study shows that, in
doing that, murine DCs are exquisitely sensitive to the dif-
ferent forms of a pathogen, a finding in line with the in-
creasingly recognized importance of pattern recognition re-
ceptors in host defense (79, 80). Considering that human
DCs also phagocytose (81) and activate T cell responses to
C. albicans (82), our findings provide important and novel
insights into the general mechanisms of immunoregulation
in fungal infections. Moreover, as the morphogenesis of C.
albicans is activated in vivo by a wide range of signals, in-
cluding stress and metabolic signals (83), DCs may also act
as key regulators of Th reactivity in saprophytism.
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